Your browser doesn't support javascript.
loading
Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes.
Schwartz, Naomi R M; Matrisian, Lynn M; Shrader, Eva E; Feng, Ziding; Chari, Suresh; Roth, Joshua A.
Afiliação
  • Schwartz NRM; CHOICE Institute, Department of Pharmacy, University of Washington, Seattle, Washington.
  • Matrisian LM; Pancreatic Cancer Action Network, Manhattan Beach, California.
  • Shrader EE; Pancreatic Cancer Action Network, Manhattan Beach, California.
  • Feng Z; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; and.
  • Chari S; Department of Gastroenterology and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roth JA; CHOICE Institute, Department of Pharmacy, University of Washington, Seattle, Washington.
J Natl Compr Canc Netw ; 20(5): 451-459, 2021 06 21.
Article em En | MEDLINE | ID: mdl-34153945
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Diabetes Mellitus Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Diabetes Mellitus Idioma: En Ano de publicação: 2021 Tipo de documento: Article